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Background: The relationship of aortic valve dysfunction and ascending aortic aneurysm is unclear in adults
with bicuspid aortic valve disease.
Methods: We retrospectively studied 134 consecutive out-patients (98 men, 36 women aged 43±18 years)
with bicuspid aortic valve disease. To investigate the relationship of ascending aortic aneurysm and aortic
valve dysfunction we exclusively considered severe pathologies that required treatment by surgical or
percutaneous intervention.
Results: Of 134 patients, 39 had aortic valve dysfunction without concomitant ascending aortic aneurysm
which had been treated previously with isolated valve surgery or percutaneous valvuloplasty comprising 25
patients with aortic stenosis (19%) and 14 patients with aortic regurgitation (10%). Conversely, 26 patients
had ascending aortic aneurysm which had been treated previously with aortic surgery (19%). Of these,
ascending aortic aneurysm was associated with severe aortic stenosis in 13 patients and with severe aortic
regurgitation in 7 patients, whereas aneurysm was unrelated to severe aortic valve dysfunction in the
remaining 6 patients including 2 without any degree of aortic valve dysfunction. The maximal aortic
diameters were similar at the time of aortic surgery irrespective of presence of severe aortic valve dysfunction
(P=.527). Other characteristics of patients with ascending aortic aneurysm were also similar irrespective of
presence or type of aortic valve dysfunction.
Conclusion: The majority of patients with bicuspid aortic valve disease exhibit ascending aortic aneurysm in
conjunction with severe aortic valve dysfunction. However, in our study 6 of 134 (5%) of persons with
bicuspid aortic valve disease developed ascending aortic aneurysm without aortic valve dysfunction.
© 2011 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Bicuspid aortic valve disease is present in 0.5% to 2% of the normal
population, and affected adults are at risk for aortic valve dysfunction
(AVD) both with severe stenosis and regurgitation [1]. Moreover, the
aorta of patients with bicuspid aortic valve disease exhibits larger
diameters [2], reduced arterial elasticity [3,4] and increased degen-
eration of the aortic medial layer [5]. It is unclear, however whetherand Cardiovascular Surgery,
pital Hamburg - Eppendorf,
y. Tel.: +49 40 7410 57328;
h).
Ltd. All rights reserved.these aortic changes relate to hemodynamic forces from aortic valve
dysfunction or whether such aortic abnormalities relate to aortic
tissue weakness resulting from genetic defects. Accordingly, there is
no consensus whether bicuspid aortic valve disease carries a
signiﬁcant risk for aortic dissection and rupture independently of
AVD and whether it is justiﬁed to replace the proximal aorta at lower
thresholds than in patients with a tricuspid aortic valve even despite
the absence of severe AVD [6–8]. We investigated 134 consecutive
persons with bicuspid aortic valve disease to elucidate the relation-
ship of ascending aortic aneurysm (ACA) and AVD. To this end we
considered ACA and AVD only in those patients who required surgical
or percutaneous intervention and we compared their ﬁndings to
persons with bicuspid aortic valve disease who did not exhibit severe
aortic or aortic valve pathology and who did not require surgery or
intervention.
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We considered all patients for inclusion in our analysis that we identiﬁed with
bicuspid aortic valve disease during a three-year interval at our out-patient unit. Of 190
consecutive out-patients with bicuspid aortic valve disease we excluded 23 individuals
because surgical reports of previous aortic valve surgery or percutaneous valvuloplasty
were not available, 13 because they fulﬁlled criteria of syndromes such as Marfan,
Turner, Noonan or Down, 12 because they exhibited complex cardiovascular
malformations including unrepaired aortic coarctation, and 8 because they had
undergone percutaneous valvuloplasty for aortic valve stenosis at an age b16 years.
The remaining 134 individuals constituted our study group that comprised 98 men and
36 women with a mean age of 43±18 years (median 43, range 16–77 years, Table 1).
To investigate the relationship of ACA and AVD we exclusively considered severe
pathologies that required surgery or intervention. Thus, we screened patient ﬁles for
any surgery or intervention at the site of the aortic valve or the ascending aorta. Severe
AVD was present with previous aortic valve replacement or aortic valve reconstruction
or with previous percutaneous balloon aortic valvuloplasty [9] as detailed in Table 1.
ACA was present with previous aortic surgery comprising ascending aortic reduction
aortoplasty both with (3 patients) or without external reinforcement (7 patients) [10],
isolated supracoronary replacement of the ascending aorta (2 patients), supracoronary
replacement of the ascending aorta combined with aortic valve replacement according
to Wheat (6 patients) [11], replacement of the ascending aorta and aortic valve with a
valved conduit and direct reimplantation of the coronary arteries according to Bentall
(4 patients) [12], or a valve-sparing root replacement according to David and as
classiﬁed David-I according to Miller (4 patients; Table 1) [13].
We assessed clinical variables from patient ﬁles and original echocardiographic
recordings at the time directly before surgery or intervention and in the remaining
individuals we assessed these variables from the time of their visit at our out-patient
unit during the study period. We present body weight and body height as documented
in the ﬁles, using these data to calculate body mass index and body surface area [14].
Any documentation of inhalative intake of nicotine for ≥1 year within the last 10 years
was considered to be a positive history of smoking. Fasting lipid levels and resting blood
pressures had been obtained at our institution, and the use of antihypertensive
medication was recorded if there was any documented intake of beta-blockers,
angiotensin-converting enzyme inhibitors, or angiotensin-receptor blockers of any
dosage and at any combination of these drugs. We screened all patient ﬁles for a history
of correction of coarctation of the aorta.
We re-evaluated preoperative or ambulatory echocardiographic recordings to
assess maximum diameters of the aorta at the level of the aortic root and at the
proximal ascending aorta as described by Roman et al [15]. We calculated 95th
percentiles of normal diameters at the aortic sinuses and at the level of the ascending
aorta as proposed by Biaggi et al [16], and we considered aortic aneurysm with any of
the observed aortic diameters N95th percentile of these calculated normal diameters.
We diagnosed a bicuspid aortic valve according to classical criteria on 2-dimensional
echocardiograms [17], and as recorded during surgery. We documented fusion of the
right and left coronary cusp (R–L type), or fusion of the right and non-coronary cusp
(R–N type) as described by Fernandez et al.[18]. We identiﬁed mild or moderate aortic
valve stenosis or regurgitation according to current recommendations [20]. DuringTable 1
Severe aortic valve dysfunction (AVD) or ascending aortic aneurysm (ACA), or both in 134
Pathology All persons Males
Total number of patients 134 98
Severe aortic valve stenosis 25 (19%)
- Isolated stenosis 12 5
- Leading stenosis 13 10
Severe aortic valve regurgitation 14 (10%)
- Isolated regurgitation 11 10
- Leading regurgitation 3 3
Ascending aortic aneurysm 26 (19%)
- With severe aortic valve stenosisa 13 10
- With severe aortic valve regurgitationb 7 5
- Without severe aortic valve dysfunctionc 6 3
Aortic valve endocarditis 8 (6%) 7
No severe aortic or aortic valve pathology 61 (46%) 43
Other AVD comprised:




aAscending aortic aneurysm with previous aortic reduction aortoplasty with (N=1) or wi
(=1). Five of 13 persons exhibited grad II aortic regurgitation in addition to their server ao
bAscending aortic aneurysm with previous aortic reduction aortoplasty with (N=2) or wi
(N=3). None of these 7 patients exhibited any degree of concomitant aortic valve stenosis
cAscending aortic aneurysm with previous supracoronary replacement of the aorta withoure-evaluation we resolved incongruent ﬁndings by re-evaluating our measurements
jointly with 2 additional echocardiographers using a consensus method. When
echocardiographic images were not available for reevaluation, we derived echocar-
diographic data from patient ﬁles.
Unless otherwise speciﬁed, we expressed quantitative data as means (± standard
deviation), and qualitative data as numbers and proportions (percentage). We
compared qualitative data by the Freeman-Halton test and quantitative data by the
Kruskal-Wallis test (Tables 2 and 3). We considered P values as descriptive measures
with a value Pb .05 as an indicator of inhomogeneity between groups of patients. We
used SPSS software (SPSS for Windows, Release 17.0, SPSS Inc. 1993 to 2007, Chicago,
Illinois) for all statistical analyses. The authors of this manuscript have certiﬁed that
they comply with the Principles of Ethical Publishing in the International Journal of
Cardiology.3. Results
Of 134 patients, 39 had severe AVD without ACA which had been
treated previously with isolated valve surgery or percutaneous
valvuloplasty comprising 25 patients with aortic stenosis (19%) and
14 patients with aortic regurgitation (10%; Table 1). Conversely, 26
patients had ACA which had been treated previously with aortic
surgery (19%). Of the remaining 69 patients without severe AVD or
ACA, 8 patients had previously undergone surgery for aortic valve
endocarditis (6%), whereas the remaining 61 individuals had not
undergone any operation or intervention (46%).
Demographic and clinical variables were similar in severe AVD
with previous surgery or intervention for aortic stenosis, in severe
AVD with previous surgery for aortic regurgitation and in patients
without severe AVD (Table 2). However, the ascending aortic
diameters tended to be larger in AVD with severe aortic stenosis
(P=.085), and the R–L type of bicuspid aortic valve was somewhat
more frequent in AVD with severe aortic regurgitation (P=.08).
Interestingly, ACA was present in 13 of 38 patients with severe aortic
stenosis (34%), in 7 of 21 patients with severe aortic regurgitation
(33%), and in 6 of 75 patients without severe AVD (6%; P=.001). The
diameters of the aortic root (P=.004) and of the ascending aortawere
signiﬁcantly larger in patients with ACA than in patients with severe
AVD without ACA (Pb .001; Fig. 1).
Of the 26 patients with ACA 13 individuals had concomitant severe
aortic stenosis, 7 had concomitant severe aortic regurgitation, and 6
did not exhibit any severe AVD. Of these 6 patients 4 exhibited mildadults with bicuspid aortic valve disease.
Median age,
years (range)
Aortic valve surgery or valvuloplasty
Bileaﬂet device Biological device Other
43 (16–77)
46 (16–61) 5 3 41
52 (19–74) 5 6 22
42 (20–71) 2 5 42
34 (17–75) 3
59 (24–73) 5 7 12
51 (18–67) 4 2 13
43 (35–60)
26 (17–55) 2 4 22
39 (16–77)*
thout external reinforcement (N=6), Wheat procedure (N=5), or Bentall procedure
rtic valve stenosis.
thout external reinforcement (N=1), Wheat procedure (N=1), or Bentall procedure
.
t aortic valve replacement (N=2), or with a David-I procedure (N=4).
Table 3
Characteristics of 26 patients with ascending aortic aneurysm (ACA).
Characteristic Ascending aortic aneurysm P*
No. AVD Aortic valve stenosis Aortic valve regurgitation
(N=6) (N=13) (N=7)
Male sex 5 10 5 .994
Age (years) 44 (39–60) 59 (24–73) 51 (18–67) .344
Aortic valve stenosis .001
- mild degree 1
- moderate degree
- severe degree 13
Aortic valve regurgitation .001
- mild degree 1 4
- moderate degree 1 5
- severe degree 7
Previous surgery for aortic coarctation 1 1 1 .821
Aortic root diameter (mm) 41 (37–61) 38 (30–46) 43 (38–48) .204
Ascending aortic diameter (mm) 49 (37–71) 47 (43–57) 52 (35–65) .852
Bicuspid valve R–L type (vs R–N type) 3/4 6/11 4/5 .549
Aortic root N95th percentile 4/5 3/6 2/3 .583
Ascending aorta N95th percentile 5/6 11/11 6/6 .227
Diameter ascending aortaNaortic root 4/5 6/7 2/3 .788
Quantitative data are given as median and range.
AVD indicates severe aortic valve dysfunction.
* Freeman-Halton test for categorical variables and the Kruskal-Wallis test for continuous variables.
Table 2
Characteristics of 134 persons according to severe aortic valve dysfunction (AVD).
Characteristic Severe aortic valve dysfunction P3
None1,2 (N=75) Stenosis2 (N=38) Regurgitation2 (N=21)
Male sex 55 (73%) 25 (66%) 18 (86%) .255
Age (years) 41±17 47±18 45±20 .149
Body height (m) 176±11 174±8 178±9 .476
Body weight (kg) 76±16 76±15 76±15 .152
Body mass index (kg/m2) 24±4 25±4 25±4 .093
Body surface area (m2) 1.92±.24 1.92±.19 2±.15 .280
History of smoking 17 (37%) 15 (54%) 6 (40%) .365
Total cholesterol (mg/dl) 191±59 193±58 167±56 .524
High-density lipoprotein cholesterol (mg/dl) 51±12 50±13 39±17 .175
Low-density lipoprotein cholesterol (mg/dl) 118±37 125±62 87±46 .259
Systolic blood pressure (mmHg) 130±20 130±22 133±25 .848
Diastolic blood pressure (mmHg) 78±11 81±15 74±18 .229
Intake of antihypertensive medication 24 (55%) 10 (48%) 6 (50%) .863
Previous surgery for aortic coarctation 17 (23%) 16 (16%) 3 (14%) .554
Left ventricular ejection fraction (%) 58±13 54±9 60±7 .561
Aortic root diameter (mm) 36±7 34±7 36±4 .587
Ascending aortic diameter (mm) 38±9 43±8 41±9 .085
Bicuspid valve R–L type (vs R–N type) 37/45 (82%) 16/27 (59%) 9/11 (82%) .080
Surgery for ascending aortic aneurysm 6 (8%) 13 (34%) 7 (33%) .001
1 Including patients with surgery for aortic valve endocarditis.
2 Including patients with concomitant ascending aortic aneurysm.
3 Freeman-Halton test for categorical variables and the Kruskal-Wallis test for continuous variables.
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any degree of aortic regurgitation or stenosis (Table 3). Patients with
ACA tended to be older with severe aortic stenosis (P=.347; Fig. 2,
left panel), but themaximal aortic diameters were similar irrespective
of presence or type of severe AVD (P=.527; Fig. 2, right panel).
4. Discussion
To study the relationship of ACA and AVD we exclusively
considered pathologies which were marked enough to require
surgery or valvuloplasty. With usage of these criteria we found that
ACA developed in three different settings comprising severe aortic
stenosis, severe aortic regurgitation, and absence of severe AVD. In the
following we discuss these three types of ACA.
In our study 50% of ACA was associated with severe aortic stenosis.
Like in other series [1,22] aortic stenosis was the most frequent causefor surgery in the entire group of patients with bicuspid aortic valve.
However, ACA was present in 34% of all patients with severe aortic
stenosis and in 33% of all patients with severe aortic regurgitation and
thus the relative frequency of ACA was similar in both types of AVD.
ACA with bicuspid aortic valve stenosis was often addressed as
“post-stenotic dilatation” which was typically reported in the
mid-ascending aorta [19]. However, we observed that the R–N type
of the bicuspid aortic valve was somewhat more prevalent both in
severe isolated aortic stenosis and in severe aortic stenosis with ACA.
Thus, speciﬁc aortic tissue mechanisms [19] yielding distinct ﬂow
patterns [20] may have contributed to the formation of ACA in aortic
stenosis.
Twenty-seven percent of ACA was associated with severe isolated
aortic regurgitation. In total, 33% of our patients with severe aortic
regurgitation had ACA, which was similar to the 43% reported by
Boodhwani et al [25]. The R–L type of bicuspid aortic valve diseasewas
Fig. 1. The scatter dot plot displays aortic diameters and the median is shown as a horizontal line. Patients with ACA (median 41 mm, range 30–61 mm) exhibited increased
diameters of the aortic root as compared to patients without ACA but with severe aortic stenosis (median 29 mm, range 18–42 mm) or with severe aortic regurgitation (median
35 mm, range 29–38 mm; P=.004; left panel). Similarly, patients with ACA (median 48 mm, range 35–71 mm) had larger diameters of the ascending aorta than patients without
ACA but with severe aortic stenosis (median 38 mm, range 26–47 mm) or with severe aortic regurgitation (median 38 mm, range 23–46 mm; Pb .001; right panel). Measurements of
the aortic root were available in 15 (58%), 8 (32%), and in 9 (64%) patients with ACA, and patients without ACA but severe aortic stenosis or regurgitation, respectively. Similarly,
measurements of the ascending aorta were available in 25 (96%), 15 (60%), and in 10 (71%) patients with ACA, and in patients without ACA but severe aortic stenosis or regurgitation,
respectively.
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only in 16 of 27 patients with severe aortic valve stenosis (59%;
P=.080). These data conﬁrm the ﬁnding by Schaefer et al. that the
R–L type of the bicuspid aortic valve tends to be more prevalent in
aortic valve regurgitation. Thus, we found support for their hypothesis
that anatomical subtypes of bicuspid aortic valves may relate to the
natural course of bicuspid aortic valve disease[21]. Moreover, our
patients with ACA and severe aortic regurgitation did not exhibit any
degree of aortic stenosis, some tended to be younger than those with
ACA related to severe aortic stenosis, not all had a dilatation at the
level of the aortic root, and with a single exception all patients
exhibited the R–L type of bicuspid valve. These ﬁndings support the
notion that ACA in the setting of aortic regurgitation relate to various
potential mechanisms [22].
Twenty-three percent of ACA was unrelated to severe AVD. This
type represented the smallest group of ACA in our study. Affected
persons were nearly all males, they usually exhibited the R–L-type of
valve, and their age at surgery was similar to the other patients with
ACA. Two patients exhibited ACAwith diameters of 65 and 71 mm but
they both had well functioning aortic valves with mild regurgitation
in one person. Two other individuals with only marginally enlarged
ascending aortic diameters of 41 and 44 mm required surgery for
rupture of aneurysm of the aortic sinus or for concomitant dilatation
of the aortic arch. One of these patients had a mild aortic stenosis
which may have accounted for ACA [6–8]. However, another
individual with a diameter of 52 mm exclusively exhibited a mild
degree of aortic regurgitation, and a person with an aortic diameter of
54 mm did not have any measurable AVD. Thus, ACA without AVDFig. 2. The scatter dot plot displays age and maximal aortic diameters and their median (hori
be older with ACA combined with severe aortic valve stenosis (median 59 years, range 24–7
ACA with severe aortic regurgitation (median 51 years, range 18–67 years; P=.347; left pa
patients without AVD (median 53 mm, range 41–71 mm) and patients with severe aortic st
65 mm; P=.527; right panel).seems to comprise a heterogeneous group of aortic pathologies, of
which some form without any degree of AVD. Affected persons may
usually be asymptomatic and thus remain unidentiﬁed until aortic
rupture or dissection.
Amajority of patientswith severeAVDdid not have ACA at the time
of aortic valve surgery, which indicates that hemodynamic factors
alone may not be enough to cause ACA in all bicuspid aortic valves.
However, we did not follow these patients and thus we are unable to
exclude that aortic dilatation developed in the postsurgical course.
Progression of aortic diameters were described after isolated aortic
valve surgery in bicuspid aortic valve disease [23], but Girdauskas et al.
concluded from their systematic review of the literature that the
available datawere not sufﬁcient to elucidate the natural history of the
proximal aorta after isolated aortic valve replacement [24].
Some limits of our study need to be mentioned. First, our study was
retrospective and we did not have complete data for all variables
(Tables 2 and 3). Second, we do not have sufﬁcient follow-up infor-
mation for postsurgical analyses. Third, a population based study of
asymptomatic persons with the incidental ﬁnding of bicuspid aortic
valve disease and rule-out of moderate or severe AVD presented the
mild end of the disease [25]. Conversely, our experience from a tertiary
care center focused on the severe end of the disease. However, since we
aimed to elucidate the relationship of AVD and severe aortic vessel
disease the study of mild phenotypes would not have been informative.
We conclude that a majority of patients with bicuspid aortic valve
disease exhibit ACA in conjunction with severe AVD. However, in our
study 25 of 38 (66%) of patients with severe aortic valve stenosis and
14 of 21 (67%) patients with severe aortic valve regurgitation did notzontal lines) at the time of surgery for ACA. Age was similar although patients tended to
3 years) than in isolated ACA without AVD (median 44 years, range 35–60 years) or in
nel). All maximal aortic diameters were ≥4 cm with no signiﬁcant difference between
enosis (median 48 mm, range 43–57 mm) or regurgitation (median 48 mm, range 43–
305A. Aydin et al. / International Journal of Cardiology 164 (2013) 301–305exhibit ACA at the time of aortic valve operation. Moreover, 6 of 134
(5%) of persons with bicuspid aortic valve disease developed ACA
without AVD. Thus in bicuspid aortic valve disease ACA is likely
caused by a broad variety of factors and it can develop in the absence
of any AVD as deﬁned by echocardiographic criteria.
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